The Smart Pump Study

Running, not enrolling · Not applicable

Conditions studied: Cardiac Output

In brief

To demonstrate that the Impella® Hemodynamic Platform (the "Study Device") is safe, and measurements obtained are as good as currently used methods. These measurements include how much pressure the heart is generating and how much blood your heart is pumping during the PCI.

Key facts

Study ID

NCT04465201

Run by

Abiomed Inc.

People needed

35

Starts

2020-11-02

Expected to finish

2022-12-31

Last updated by the study team

2022-10-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• Subject presents for elective PCI
• Subject or the subject's LAR has signed the informed consent
• Subject indicated for Impella® support

You may not qualify if…

• Any contraindication or inability to place an Impella® including tortuous vascular anatomy, femoral bruits or absent pedal pulses
• Cardiogenic shock defined as systemic hypotension (SBP<90mmHg or the need for inotropes/vasopressors to maintain an SBP >90mmHg) plus one of the following:
• Any requirement for inotropes/vasopressors prior to arrival at the catherization lab
• Clinical evidence of end organ hypoperfusion
• Use of IABP or any other circulatory support device
• Suspected systemic active infection
• Suspected or known pregnancy
• Known contraindication to heparin, pork, pork products, or contrast media
• Subject has other medical, social, or psychological problems that, in the opinion of the Investigator, compromises the subject's ability to give written informed consent and/or to comply with study procedures
• Participation in the active treatment or follow-up phase of another clinical study of an investigational drug or device which has not reached its primary end point.
• Subject belongs to a vulnerable population [Vulnerable subject populations are defined as individuals with mental disability, persons in nursing homes, children, impoverished persons, homeless persons, nomads, refugees, and those permanently incapable of giving informed consent. Vulnerable populations also may include members of a group with a hierarchical structure such as university students, subordinate hospital and laboratory personnel, employees of the Sponsor, members of the armed forces, and persons kept in detention

Where it is running

• Ochsner Clinical Foundation — New Orleans, Louisiana, United States
• Brigham & Women's Hospital — Boston, Massachusetts, United States
• Henry Ford Hospital — Detroit, Michigan, United States
• Ascension St. John Hospital — Detroit, Michigan, United States
• Spectrum Health — Grand Rapids, Michigan, United States
• Columbia University Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.